Literature DB >> 35366418

CCT2 is an aggrephagy receptor for clearance of solid protein aggregates.

Xinyu Ma1, Caijing Lu1, Yuting Chen2, Shulin Li1, Ningjia Ma1, Xuan Tao1, Ying Li1, Jing Wang3, Min Zhou4, Yong-Bin Yan3, Pilong Li4, Kartoosh Heydari5, Haiteng Deng6, Min Zhang7, Cong Yi8, Liang Ge9.   

Abstract

Protein aggregation is a hallmark of multiple human pathologies. Autophagy selectively degrades protein aggregates via aggrephagy. How selectivity is achieved has been elusive. Here, we identify the chaperonin subunit CCT2 as an autophagy receptor regulating the clearance of aggregation-prone proteins in the cell and the mouse brain. CCT2 associates with aggregation-prone proteins independent of cargo ubiquitination and interacts with autophagosome marker ATG8s through a non-classical VLIR motif. In addition, CCT2 regulates aggrephagy independently of the ubiquitin-binding receptors (P62, NBR1, and TAX1BP1) or chaperone-mediated autophagy. Unlike P62, NBR1, and TAX1BP1, which facilitate the clearance of protein condensates with liquidity, CCT2 specifically promotes the autophagic degradation of protein aggregates with little liquidity (solid aggregates). Furthermore, aggregation-prone protein accumulation induces the functional switch of CCT2 from a chaperone subunit to an autophagy receptor by promoting CCT2 monomer formation, which exposes the VLIR to ATG8s interaction and, therefore, enables the autophagic function.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CCT2; FUS; GABARAP; Huntington’s disease; LC3; NBR1; P62; SOD1; TAX1BP1; TRiC; aggrephagy; autophagy; chaperone; chaperonin; huntingtin; neurodegeneration; phase separation; protein aggregates; protein aggregation; tau

Mesh:

Substances:

Year:  2022        PMID: 35366418     DOI: 10.1016/j.cell.2022.03.005

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  6 in total

1.  The contribution of proteasomal impairment to autophagy activation by C9orf72 poly-GA aggregates.

Authors:  Mei Pu; Yusi Tai; Luyang Yuan; Yu Zhang; Huijie Guo; Zongbing Hao; Jing Chen; Xinming Qi; Guanghui Wang; Zhouteng Tao; Jin Ren
Journal:  Cell Mol Life Sci       Date:  2022-08-29       Impact factor: 9.207

2.  CCT2, a newly identified aggrephagy receptor in mammals, specifically mediates the autophagic clearance of solid protein aggregates.

Authors:  Zhihai Zhang; Daniel J Klionsky
Journal:  Autophagy       Date:  2022-06-14       Impact factor: 13.391

Review 3.  Life and Death Decisions-The Many Faces of Autophagy in Cell Survival and Cell Death.

Authors:  Ge Yu; Daniel J Klionsky
Journal:  Biomolecules       Date:  2022-06-21

4.  Chaperonin-containing TCP-1 subunit 2-mediated aggrephagy: A potential target for treating neurodegeneration.

Authors:  Xueshen Chen; Min Zhang
Journal:  Clin Transl Med       Date:  2022-08

5.  Discovery of an autophagy inducer J3 to lower mutant huntingtin and alleviate Huntington's disease-related phenotype.

Authors:  Jiahui Long; Xia Luo; Dongmei Fang; Haikun Song; Weibin Fang; Hao Shan; Peiqing Liu; Boxun Lu; Xiao-Ming Yin; Liang Hong; Min Li
Journal:  Cell Biosci       Date:  2022-10-08       Impact factor: 9.584

Review 6.  Anticancer Therapeutic Strategies Targeting p53 Aggregation.

Authors:  Giulia D S Ferretti; Julia Quarti; Gileno Dos Santos; Luciana P Rangel; Jerson L Silva
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.